Circulating CTRP9 is Associated with Severity of Systemic Sclerosis-associated Interstitial Lung Disease.
Monica M YangLauren C BalmertRoberta Goncalves MarangoniMary CarnsMonique E HinchcliffBenjamin D KormanJohn VargaPublished in: Arthritis care & research (2021)
Higher circulating CTRP9 associated with worse pulmonary function while low CTRP9 identified patients with lung disease stability over time. These findings suggest that CTRP9 may be a potential biomarker in SSc-associated ILD.